| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $21K | -83.0% |
| Cost of Revenue | $53K | -86.0% |
| Gross Profit | -$32K | +87.4% |
| R&D Expense | $8.4M | +15.0% |
| SG&A Expense | $5.4M | -4.3% |
| Operating Income | -$13.8M | -4.8% |
| Pre-tax Income | -$14.9M | -7.9% |
| Income Tax | $800 | +0.0% |
| Net Income | -$14.9M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.9M | +106.5% |
| Accounts Receivable | $56 | -87.7% |
| Inventory | $144K | -14.2% |
| Current Assets | $4.3M | +75.4% |
| Total Assets | $28.8M | -9.5% |
| Current Liabilities | $4.0M | +195.8% |
| Total Liabilities | $13.3M | +79.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$5.8M | -23.7% |
| Capital Expenditures | $21K | -77.1% |
| Investing Cash Flow | -$125K | -23.4% |
| Financing Cash Flow | $8.0M | +63.0% |
| Free Cash Flow | -$5.8M | -21.8% |
| -7.9% |
| EPS (Basic) | -$1.56 | +53.6% |
| EPS (Diluted) | -$1.56 | +53.6% |
| Stockholders' Equity |
| $15.5M |
| -36.5% |